The per capita sales of antibacterial medicines in Italy are projected to decline from 12.5 US dollars in 2024 to 11.7 US dollars by 2028. This reflects a decreasing trend over the five-year forecast period, indicating a year-on-year decline: 2025 witnesses a reduction of approximately 2.4%, 2026 experiences a 1.6% drop, while the decline moderates slightly to 1.7% in 2027, and further to 0.8% in 2028. The compound annual growth rate (CAGR) over these five years suggests a modest downward trajectory.

Future trends to watch for:

Changes in healthcare policies affecting antibiotic usage and sales.
Impact of increased awareness of antibiotic resistance on prescription practices.
Emerging developments in alternative therapies reducing antibiotic demand.